Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method

An audit of the practices of our compounding unit was performed in 2016: areas of improvement were proposed, such as the automatization of our process. An automated compounder was acquired (MediMixmulti® MF4120R). The aim of the study was to anticipate the risks of the new process, in order to impro...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dozias Gautier, Thiec Julie, Le Den Gwenola, Cogulet Virginie
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	hazard analysis and critical control points neonatology parenteral nutrition risk management Therapeutics. Pharmacology RM1-950 Pharmaceutical industry HD9665-9675
Acceso en línea:	https://doaj.org/article/6855c1c3c5804c58a15bf61194a6fa7b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6855c1c3c5804c58a15bf61194a6fa7b
record_format	dspace
spelling	oai:doaj.org-article:6855c1c3c5804c58a15bf61194a6fa7b2021-12-05T14:11:02ZRisks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method2365-24112365-242X10.1515/pthp-2020-0017https://doaj.org/article/6855c1c3c5804c58a15bf61194a6fa7b2021-02-01T00:00:00Zhttps://doi.org/10.1515/pthp-2020-0017https://doaj.org/toc/2365-2411https://doaj.org/toc/2365-242XAn audit of the practices of our compounding unit was performed in 2016: areas of improvement were proposed, such as the automatization of our process. An automated compounder was acquired (MediMixmulti® MF4120R). The aim of the study was to anticipate the risks of the new process, in order to improve its security and to support the professionals during this evolution of our compounding process.Dozias GautierThiec JulieLe Den GwenolaCogulet VirginieDe Gruyterarticlehazard analysis and critical control pointsneonatologyparenteral nutritionrisk managementTherapeutics. PharmacologyRM1-950Pharmaceutical industryHD9665-9675ENPharmaceutical Technology in Hospital Pharmacy, Vol 6, Iss 1, Pp 63-72 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	hazard analysis and critical control points neonatology parenteral nutrition risk management Therapeutics. Pharmacology RM1-950 Pharmaceutical industry HD9665-9675
spellingShingle	hazard analysis and critical control points neonatology parenteral nutrition risk management Therapeutics. Pharmacology RM1-950 Pharmaceutical industry HD9665-9675 Dozias Gautier Thiec Julie Le Den Gwenola Cogulet Virginie Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
description	An audit of the practices of our compounding unit was performed in 2016: areas of improvement were proposed, such as the automatization of our process. An automated compounder was acquired (MediMixmulti® MF4120R). The aim of the study was to anticipate the risks of the new process, in order to improve its security and to support the professionals during this evolution of our compounding process.
format	article
author	Dozias Gautier Thiec Julie Le Den Gwenola Cogulet Virginie
author_facet	Dozias Gautier Thiec Julie Le Den Gwenola Cogulet Virginie
author_sort	Dozias Gautier
title	Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
title_short	Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
title_full	Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
title_fullStr	Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
title_full_unstemmed	Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method
title_sort	risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “fmeca” method
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/6855c1c3c5804c58a15bf61194a6fa7b
work_keys_str_mv	AT doziasgautier risksassociatedwiththeevolutioninthecompoundingprocessofparenteralnutritionsolutionsuseofthefmecamethod AT thiecjulie risksassociatedwiththeevolutioninthecompoundingprocessofparenteralnutritionsolutionsuseofthefmecamethod AT ledengwenola risksassociatedwiththeevolutioninthecompoundingprocessofparenteralnutritionsolutionsuseofthefmecamethod AT coguletvirginie risksassociatedwiththeevolutioninthecompoundingprocessofparenteralnutritionsolutionsuseofthefmecamethod
_version_	1718371477989883904

Risks associated with the evolution in the compounding process of parenteral nutrition solutions: use of the “FMECA” method

Ejemplares similares